TR199800729T2 - Eritmeli ekstr�zyonla haz�rlanan siklodekstrin kat� kar���mlar�. - Google Patents

Eritmeli ekstr�zyonla haz�rlanan siklodekstrin kat� kar���mlar�.

Info

Publication number
TR199800729T2
TR199800729T2 TR1998/00729T TR9800729T TR199800729T2 TR 199800729 T2 TR199800729 T2 TR 199800729T2 TR 1998/00729 T TR1998/00729 T TR 1998/00729T TR 9800729 T TR9800729 T TR 9800729T TR 199800729 T2 TR199800729 T2 TR 199800729T2
Authority
TR
Turkey
Prior art keywords
melt extrusion
solid mixtures
cyclodextrin
cyclodextrin prepared
prepared
Prior art date
Application number
TR1998/00729T
Other languages
English (en)
Turkish (tr)
Inventor
Elvire Colette Baert Lieven
Peeters Jozef
Verreck Geert
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26139823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR199800729(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of TR199800729T2 publication Critical patent/TR199800729T2/xx

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TR1998/00729T 1995-11-23 1996-11-20 Eritmeli ekstr�zyonla haz�rlanan siklodekstrin kat� kar���mlar�. TR199800729T2 (xx)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95203219 1995-11-23
US09/081,808 US6365188B1 (en) 1995-11-23 1998-05-20 Solid mixtures of cyclodextrins prepared via meltextrusion

Publications (1)

Publication Number Publication Date
TR199800729T2 true TR199800729T2 (xx) 1998-07-21

Family

ID=26139823

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00729T TR199800729T2 (xx) 1995-11-23 1996-11-20 Eritmeli ekstr�zyonla haz�rlanan siklodekstrin kat� kar���mlar�.

Country Status (16)

Country Link
US (1) US6365188B1 (fr)
EP (1) EP0862463A1 (fr)
JP (1) JP3310299B2 (fr)
CN (1) CN1198655C (fr)
AU (1) AU725204B2 (fr)
BR (1) BR9611562A (fr)
CZ (1) CZ154398A3 (fr)
HU (1) HUP9900730A3 (fr)
IL (1) IL123654A (fr)
NO (1) NO981078L (fr)
NZ (1) NZ322907A (fr)
PL (1) PL189122B1 (fr)
SK (1) SK67298A3 (fr)
TR (1) TR199800729T2 (fr)
WO (1) WO1997018839A1 (fr)
ZA (1) ZA969831B (fr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ154398A3 (cs) * 1995-11-23 1998-08-12 Janssen Pharmaceutica N.V. Pevné směsi cyklodextrinů připravené vytlačováním taveniny
KR19990001564A (ko) 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
CA2310847C (fr) 1997-11-28 2007-03-13 Knoll Aktiengesellschaft Procede permettant de fabriquer des substances biologiquement actives, depourvues de solvants et non cristallines
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
CZ301367B6 (cs) 1998-11-10 2010-02-03 Janssen Pharmaceutica N. V. Derivát pyrimidinu, zpusob a meziprodukty pro jeho prípravu a lécivo pro lécení HIV na jeho bázi
US6194395B1 (en) 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations
DE19911097A1 (de) * 1999-03-12 2000-09-14 Basf Ag Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
ATE307808T1 (de) 1999-03-24 2005-11-15 Scherer Technologies Inc R P Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
JP4610744B2 (ja) 1999-05-04 2011-01-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 抗菌・抗カビ性エーテル類
FR2803748A1 (fr) * 2000-01-14 2001-07-20 Ethypharm Lab Prod Ethiques Composition d'itraconazole et procede de preparation
AU3740101A (en) 2000-03-01 2001-09-12 Janssen Pharmaceutica Nv 2,4-disubstituted thiazolyl derivatives
US6835717B2 (en) * 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
JP5230050B2 (ja) 2000-05-08 2013-07-10 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｈｉｖ複製阻害剤
ITRN20000051A1 (it) 2000-12-22 2002-06-22 Ascor Chimici Srl Metodo e apparecchiatura per formare sferule composite contenenti principi attivi del tipo farmaceutico e/o integratori alimentari o cosmeti
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
IL160329A0 (en) 2001-08-13 2004-07-25 Janssen Pharmaceutica Nv 2-amino-4,5-trisubstituted thiazolyl derivatives
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
WO2003075929A1 (fr) 2002-03-13 2003-09-18 Janssen Pharmaceutica N.V. Inhibiteurs de l'histone déacétylase
ATE396971T1 (de) 2002-03-13 2008-06-15 Janssen Pharmaceutica Nv Sulfonylaminoderivate als neue inhibitoren von histondeacetylase
WO2004016581A1 (fr) 2002-08-09 2004-02-26 Janssen Pharmaceutica N.V. Procedes de preparation de 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
AP2005003365A0 (en) 2003-02-07 2005-09-30 Janssen Pharmaceutica Nv Hiv inhibiting 1, 2, 4-triazines.
KR20110132482A (ko) 2003-02-07 2011-12-07 얀센 파마슈티카 엔.브이. Ｈｉｖ 감염 예방용 피리미딘 유도체
CL2004000303A1 (es) 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidinas y triazinas; proceso de preparacion; composicion farmaceutica; y su uso para inhibir la replicacion del vih.
MEP34508A (en) * 2003-03-28 2011-02-10 Ares Trading Sa Cladribine formulations for improved oral and transmucosal delivery
RS20050735A (en) * 2003-03-28 2008-06-05 Ares Trading S.A., Cladribine formulations for improved oral and transmucosal delivery
DE602004031641D1 (de) 2003-09-25 2011-04-14 Janssen Pharmaceutica Nv Die replikation von hiv hemmende purinderivate
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
EA010652B1 (ru) 2004-07-28 2008-10-30 Янссен Фармацевтика Н.В. Замещенные индолильные алкиламинопроизводные в качестве новых ингибиторов гистондеацетилазы
EP1797050B1 (fr) 2004-08-10 2013-10-23 Janssen Pharmaceutica NV Dérivés de 1,2,4-triazin-6-one destinés à inhiber le hiv
TW200626574A (en) 2004-09-30 2006-08-01 Tibotec Pharm Ltd HIV inhibiting 5-heterocyclyl pyrimidines
MX2007003796A (es) 2004-09-30 2007-04-25 Tibotec Pharm Ltd Pirimidinas 5-sustituidas inhibidoras del virus de inmunodeficiencia humana.
CA2577588C (fr) 2004-10-29 2013-09-10 Tibotec Pharmaceuticals Ltd. Derives de pyrimidine bicycliques inhibant le vih
CN101107234B (zh) 2005-01-27 2013-06-19 泰博特克药品有限公司 抑制hiv的2-(4-氰基苯氨基)嘧啶衍生物
BRPI0609291B1 (pt) 2005-03-04 2022-02-08 Janssen Sciences Ireland Uc 2-(4-ciano-fenil)-o-hidroxilamina-pirimidinas que inibem hiv, composição farmacêutica que as compreende e processo para a preparação de ambas
DK1912626T3 (en) * 2005-08-08 2016-08-01 Abbvie Deutschland Dosage forms with improved bioavailability
WO2007047253A2 (fr) * 2005-10-11 2007-04-26 Eastman Chemical Company Formulations pharmaceutiques de cyclodextrines et composes antifongiques de type azole
WO2007082874A1 (fr) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Dérivés de pyridine et de pyrimidine en tant qu'inhibiteurs d'histone désacétylase
EP1832281A1 (fr) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Procédé pour la production d'une dispersion solide d'un ingredient actif
DK2004641T3 (da) 2006-03-30 2011-01-24 Tibotec Pharm Ltd HIV-inhiberende 5-(hydroxymethylen og aminomethylen) substituerede pyrimidiner
EP2004632B1 (fr) 2006-03-30 2014-03-12 Janssen R&D Ireland Pyrimidines à substitution 5-amido inhibant le vih
CN101573342A (zh) 2006-12-29 2009-11-04 泰博特克药品有限公司 抑制hiv的5,6-取代的嘧啶类化合物
JP5185283B2 (ja) 2006-12-29 2013-04-17 テイボテク・フアーマシユーチカルズ Ｈｉｖ阻害６−置換ピリミジン
AU2009243139A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Continuous process for making pharmaceutical compositions
BRPI0925048B8 (pt) 2009-05-07 2021-06-22 Gea Pharma Systems Ltd módulo para produção de comprimidos e método para a produção contínua de comprimidos
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
CN107441504A (zh) * 2017-09-06 2017-12-08 广州中医药大学 番茄红素包合物及其制备方法及番茄红素包合物片剂、胶囊和颗粒
CN110898015A (zh) * 2019-12-31 2020-03-24 上海汉维生物医药科技有限公司 一种伊曲康唑制剂的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152765A (ja) * 1984-12-27 1986-07-11 Nippon Ekishiyou Kk シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
ES2145063T3 (es) * 1992-10-14 2000-07-01 Nippon Shinyaku Co Ltd Procedimiento de dislocacion del estado cristalino.
AU5376994A (en) * 1992-11-10 1994-06-08 Nippon Shinyaku Co. Ltd. Enclosure compound manufacturing method
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.
CZ154398A3 (cs) * 1995-11-23 1998-08-12 Janssen Pharmaceutica N.V. Pevné směsi cyklodextrinů připravené vytlačováním taveniny
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
AU725204B2 (en) 2000-10-05
SK67298A3 (en) 1998-11-04
HUP9900730A3 (en) 2001-04-28
CN1200677A (zh) 1998-12-02
EP0862463A1 (fr) 1998-09-09
NO981078D0 (no) 1998-03-11
BR9611562A (pt) 1999-03-02
HUP9900730A2 (hu) 1999-07-28
PL326161A1 (en) 1998-08-31
CZ154398A3 (cs) 1998-08-12
JPH11501050A (ja) 1999-01-26
CN1198655C (zh) 2005-04-27
ZA969831B (en) 1998-05-22
US6365188B1 (en) 2002-04-02
IL123654A0 (en) 1998-10-30
IL123654A (en) 2001-08-08
NO981078L (no) 1998-05-22
PL189122B1 (pl) 2005-06-30
JP3310299B2 (ja) 2002-08-05
WO1997018839A1 (fr) 1997-05-29
AU7694396A (en) 1997-06-11
NZ322907A (en) 1998-12-23

Similar Documents

Publication Publication Date Title
TR199800729T2 (xx) Eritmeli ekstr�zyonla haz�rlanan siklodekstrin kat� kar���mlar�.
CY1105154T1 (el) Ενσωματωση δραστικων ουσιων σε μητρες ουσιων-φορεων
DE3872059D1 (de) Verfahren und vorrichtungen, um duftstoffe zu verteilen.
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
TR199701018T1 (xx) Oral 2-metil-tieno-benzodiazepin form�lasyonu.
DE3584281D1 (de) Tripeptidyl-argininaldehyde, verfahren zu ihrer herstellung und diese enthaltende arzneimittel sowie n-(monoalkyl)- und n,n-di-(alkyl)-xxx-l-prolin-dipeptide.
DE69429820T2 (de) Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
DE58908406D1 (de) Photopolymerisierbare Verbindungen, diese enthaltendes photopolymerisierbares Gemisch und daraus hergestelltes photopolymerisierbares Aufzeichnungsmaterial.
DE69631422D1 (de) Feste dispersion von rapamycin
TR199900639T2 (xx) Olanzapin dihidrat D.
GR890100846A (el) Μεθοδος μετατροπης κυτταρικης διαφοροποιησης και λειτουργιας καισυνθεσεις της.
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
DK0654991T3 (da) Inhalationspulver indeholdende antistatisk hjælpemiddel
ES472641A1 (es) Procedimiento para la obtencion de propenil-aminas
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
DE69302634D1 (de) Pfropfcopolymer, Verfahren zur Herstellung davon und dieses Copolymer als aktive Komponente enthaltende Weichmacher
DE3483204D1 (de) 4h-3,1-benzoxazin-4-ones und verwandte verbindungen, sie enthaltende pharmazeutische zusammensetzungen und verfahren ihrer herstellung.
DE3771376D1 (de) Indol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
TR199901834T2 (xx) S�lfonil �releri ve adj�van bazl� kat� kar���mlar.
DE68924233D1 (de) Entwicklerzusammensetzung und Verfahren zu deren Herstellung.
TR200000738T2 (tr) Difosjenden ve/veya trifosjenden fosjen hazırlanması için yöntem ve gereç.
TR199900403T2 (xx) Amorf benzotiofenler, haz�rlama y�ntemleri ve kullanma y�ntemleri.
AU4572889A (en) Agent for immunochemical tests which contains polymers containing carboxyl groups
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri